Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers

Carcinogenesis

Volumn 32, Issue 4, 2011, Pages 522-529

  Lim, Wei Yen ^a   Chen, Ying ^a   Ali, Safiyya Mohamed ^a   Chuah, Khoon Leong ^b   Eng, Philip ^c   Leong, Swan Swan ^d   Lim, Elaine ^b   Lim, Tow Keang ^e   Ng, Alan W K ^b   Poh, Wee Teng ^f   Tee, Augustine ^f   Teh, Ming ^e   Salim, Agus ^a   Seow, Adeline ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

^c MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

^d DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^e NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^f CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 1 BETA RECEPTOR ANTAGONIST; INTERLEUKIN 1BETA; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ALLELE; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; COMORBIDITY; CONTROLLED STUDY; CORRELATIONAL STUDY; COUGHING; DNA POLYMORPHISM; FEMALE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFLAMMATION; LIFESTYLE AND RELATED PHENOMENA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; NEVER SMOKER; PRIORITY JOURNAL; RISK ASSESSMENT; SMALL CELL CARCINOMA; TANDEM REPEAT; TUBERCULOSIS;

ADULT; AGED; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; INTERLEUKIN-6; LUNG NEOPLASMS; MIDDLE AGED; MINISATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 79953675700     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr006     Document Type: Article

References (59)

1. Boyle,P. et al. (2008) World cancer report 2008. International Agency for Research in Cancer. IARC Press, Lyon.
2. World Health Organization. (2008) WHO report on the global tobacco epidemic, 2008: The Mpower package. World Health Organisation, Geneva, Switzerland.
3. Koo,L.C. et al. (1990) Worldwide epidemiological patterns of lung cancer in nonsmokers. Int. J. Epidemiol., 19, S14-S23.
4. Toh,C.K. et al. (2006) Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J. Clin. Oncol., 24, 2245-2251.
5. Wakelee,H.A. et al. (2007) Lung cancer incidence in never smokers. J. Clin. Oncol., 25, 472-478.
6. Subramanian,J. et al. (2007) Lung cancer in never smokers: a review. J. Clin. Oncol., 25, 561-570.
7. Shigematsu,H. et al. (2005) Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancer. J. Natl Cancer Inst., 97, 339-346.
8. Brennan,P. et al. (2004) Secondhand smoke exposure in adulthood and risk of lung cancer among never smokers: a pooled analysis of two large studies. Int. J. Cancer., 109, 125-131.
9. Ko,Y.C. et al. (2000) Chinese food cooking and lung cancer in women nonsmokers. Am. J. Epidemiol., 151, 140-147.
10. Kleinerman,R.A. et al. (2002) Lung cancer and indoor exposure to coal and biomass in rural China. J. Occup. Environ. Med., 44, 338-344.
11. Darby,S. et al. (2005) Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ., 330, 223.
12. Vainio,H. et al. (2006) Fruits and vegetables in cancer prevention. Nutr. Cancer., 54, 111-142.
13. Seitz,H.K. et al. (2006) Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol. Chem., 387, 349-360.
14. Balkwill,F. et al. (2001) Inflammation and cancer: back to Virchow? Lancet., 357, 539-545.
15. Martey,C.A. et al. (2004) Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer. Am. J. Physiol. Lung Cell. Mol. Physiol., 287, L981-L91.
16. Brenner,A.V. et al. (2001) Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. Int. J. Epidemiol., 30, 118-124.
17. Wu-Williams,A.H. et al. (1990) Lung cancer among women in north-east China. Br. J. Cancer., 62, 982-987.
18. Mayne,S.T. et al. (1999) Previous lung disease and risk of lung cancer among men and women nonsmokers. Am. J. Epidemiol., 149, 13-20.
19. Hubbard,R. et al. (2000) Lung cancer and cryptogenic fibrosing alveolitis: a population based cohort study. Am. J. Respir. Crit. Care Med., 161, 5-8.
20. Koh,W.P. et al. (2008) Chronic rhinosinusitis and risk of lung cancer in the Singapore Chinese Health Study. Int. J. Cancer., 123, 1398-1402.
21. Brown,D.W. et al. (2005) Asthma and risk of death from lung cancer: NHANES II Mortality Study. J. Asthma., 42, 597-600.
22. Boffetta,P. et al. (2002) Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden. Eur. Respir. J., 19, 127-133.
23. Santillan,A.A. et al. (2003) A meta-analysis of asthma and lung cancer (United States). Cancer Causes Control., 14, 327-334.
24. Talbot-Smith,A. et al. (2003) Allergy, atopy and cancer:A prospective study of the 1981 Busselton Cohort. Am. J. Epidemiol., 157, 606-612.
25. Wang,H. et al. (2006) Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int. J. Cancer., 119, 675-701.
26. Castaing,M. et al. (2005) Is the risk of lung cancer reduced among eczema patients? Am. J. Epidemiol., 162, 542-547.
27. Zienolddiny,S. et al. (2004) Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int. J. Cancer., 109, 353-356.
28. Asada,M. et al. (2006) Interleukin-1 beta gene polymorphisms associated with risk of lung cancer in Japanese. Lung Cancer., 54, 261-263.
29. Campa,D. et al. (2005) Lack of association between polymorphisms in inflammatory genes and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 14, 538-539.
30. Vogel,U. et al. (2008) Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. Mutat. Res., 639, 89-100.
31. Engels,E.A. et al. (2007) Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res., 67, 6520-6527.
32. Lee,K.M. et al. (2007) Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis., 28, 1437-1441.
33. Seow,A. et al. (2006) Joint effect of asthma/atopy and an IL-6 gene polymorphism on lung cancer risk among lifetime non-smoking Chinese women. Carcinogenesis., 27, 1240-1244.
34. Van Dyke,A.L. et al. (2009) Cytokine and cytokine receptor singlenucleotide polymorphisms predict risk for non-small cell lung cancer among women. Cancer Epidemiol. Biomarkers Prev., 18, 1829-1840.
35. Hu,Z. et al. (2006) Allele 2 of the interleukin-1 receptor antagonist gene (IL1RN*2) is associated with a decreased risk of primary lung cancer. Cancer Lett., 236, 269-275.
36. Lind,H. et al. (2005) Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin1 beta gene. Lung Cancer., 50, 285-290.
37. Hu,Z. et al. (2005) A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population. Lung Cancer., 48, 11-17.
38. Park,J.M. et al. (2006) Relationship between cyclooxygenase 8473 T.C polymorphism and the risk of lung cancer: a case control study. BMC Cancer., 6, 70.
39. Chen,D. et al. (2008) Genetic variants in peroxisome proliferator-activated receptor c gene are associated with risk of lung cancer in a Chinese population. Carcinogenesis., 29, 342-350.
40. Seow,A. et al. (2004) Trends in Cancer Incidence in Singapore 1968-2002. Singapore Cancer Registry, Report No. 6. Singapore Cancer Registry, Singapore, Singapore.
41. Epidemiology & Disease Control Division. (2005) National Health Survey 2004. Ministry of Health, Singapore, Singapore.
42. Seow,A. et al. (2000) Fumes from meat cooking and lung cancer risk in Chinese women. Cancer Epidemiol. Biomarkers Prev., 9, 1215-1221.
43. Tang,L. et al. (2010) Lung cancer in Chinese women: evidence for an interaction between tobacco smoking and exposure to inhalants in the indoor environment. Environ. Health Perspectives., 118, 1257-1260.
44. Tarlow,J.K. et al. (1993) Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum. Genet., 91, 403-404.
45. Benjamini,Y. et al. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Statist. Soc. Ser. B., 57, 289-300.
46. Alavanja,M.C. et al. (1992) Preexisting lung disease and lung cancer among nonsmoking women. Am. J. Epidemiol., 136, 623-632.
47. Liang,H.Y. et al. (2009) Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int. J. Cancer., 125, 2936-2944.
48. Wang,X.R. et al. (2009) Previous pulmonary disease and family cancer history increase the risk of lung cancer among Hong Kong women. Cancer Causes Control., 20, 757-763.
49. Kubík,A.K. et al. (2002) Lung cancer risk among Czech women: a casecontrol study. Prev. Med., 34, 436-444.
50. Islam,S.S. et al. (1994) Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan. Cancer Epidemiol. Biomarkers Prev., 3, 289-298.
51. Salvi,S.S. et al. (2009) Chronic obstructive pulmonary disease in nonsmokers. Lancet., 374, 733-743.
52. Ker,J. et al. (2009) The atopic march: what's the evidence? Ann. Allergy Asthma Immunol., 103, 282-289.
53. Kitamura,A. et al. (2002) Interleukin-6 polymorphism (-634C/G) in the promoter region and the progression of diabetic nephropathy in Type 2 diabetes. Diabet. Med., 19, 1000-1005.
54. Colakogullari,M. et al. (2008) The involvement of IL-10, IL-6, IFN-, TNFand TGF-gene polymorphisms among Turkish lung cancer patients. Cell Biochem. Funct., 26, 283-290.
55. El-Omar,E.M. et al. (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature., 404, 398-402.
56. Wu,K.S. et al. (2010) Influence of interleukin-1 beta genetic polymorphism, smoking and alcohol drinking on the risk of non-small cell lung cancer. Clin. Chim. Acta., 411, 1441-1446.
57. Kiyohara,C. et al. (2010) IL1b rs1143634 polymorphism, cigarette smoking, alcohol use and lung cancer risk in a Japanese population. J. Thorac. Oncol., 5, 299-304.
58. Ter-Minassian,M. et al. (2008) Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer. Carcinogenesis., 29, 2147-2152.
59. Rothman,K.J. et al. (2008) Modern Epidemiology. Lippincott Williams & Wilkins, Philadelphia, PA.